Question: What engaging CD3 with one arm of a bispecific measurably achieved against chemotherapy
Survival measured for a CD3-engaging bispecific against standard chemotherapy
Collecting findings
0/2 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected